Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Nature Reviews Drug Discovery 22, 681-682 (2023)
J.M.S.W. is funded by a NIHR Research Professorship (NIHR301614).
Pushpakom, S. et al. Drug repurposing: progress, challenges and recommendations. Nat. Rev. Drug Discov. 18, 41–58 (2019).
Tang, Y., Yang, K., Zhao, J., Liang, X. & Wang, J. Evidence of repurposing drugs and identifying contraindications from real world study in Parkinson’s disease. ACS Chem. Neurosci. 10, 954–963 (2019).
Woodcock, J. & LaVange, L. M. Master protocols to study multiple therapies, multiple diseases, or both. N. Engl. J. Med. 377, 62–70 (2017).
Zheng, H., Jaki, T. & Wason, J. M. S. Bayesian sample size determination using commensurate priors to leverage preexperimental data. Biometrics 79, 669–683 (2023).
Austin, C. P., Mount, B. A. & Colvis, C. M. Envisioning an actionable research agenda to facilitate repurposing of off-patent drugs. Nat. Rev. Drug Discov. 20, 723–724 (2021).
The authors declare no competing interests.